Kategorien
-
Adhesives
5
Amines
94
Amino Acids
181
Analytical Reagents
673
Antibiotics
252
Bioactive Small Molecules
717
Aroma Chemicals
206
Biochemicals
1014
Boronic Acids
4
Buffers
99
Building Blocks
1789
Carbohydrates
176
Catalysts
100
Chiral Compounds
54
Coccus nucifera oil
0
Detergents
59
Diagnostic Raw Materials
251
Flavours and Fragrance Materials
204
Fluorinated Products
42
Furans
5
Gases in Solution
50
Grignard Reagents
23
HPLC Reagents
8
Imidazoles
17
Indoles
42
Inorganic Chemicals
326
Ion-Pair Reagents
24
Ligands
80
Organics
1312
Oxazoles
3
Peptide Reagents
90
Phenols
44
Picolines
0
Piperazines
10
Pyrazines
2
Pyridines
54
Pyrimidines
30
Quaternary Ammonium salts
44
Reagents
97
Research Organics & Inorganics
752
Salts
285
Sealing Compounds
1
Sherclin
2
Solvents
124
Stains & Indicators
289
Sugars
63
Tailor-made solutions
3
Testing Standards
4
Uncategorised
191
Water Analysis
10
Naproxen
(25190315 | 22204-53-1)
| CAS: | 22204-53-1 |
|---|---|
| Molekularformel: | CH3OC10H6CH(CH3)CO2H |
| Molekulargewicht: | 230.26 |
| Verfügbarkeit: | Auf Lager |
|---|---|
| Downloads: | | |
Für dieses Produkt wird ein Gefahrstoffzuschlag erhoben. Der genaue Betrag wird von unserem Verkaufsteam bestätigt.
| 25190315-5g | 5g | £51.40 | |
| Bulk Menge | |||
| 25190315-5g | 5g | €72.00 | |
| Bulk Menge | |||
| 25190315-5g | 5g | $77.10 | |
| Bulk Menge | |||
Sicherheitsdatenblatt
Analysezertifikat
Produktbeschreibung
| Product Code | 25190315 | ||||
| Product Name | Naproxen | ||||
| Categories | Uncategorised | ||||
| CAS | 22204-53-1 | ||||
| Molecular Formula | CH3OC10H6CH(CH3)CO2H | ||||
| Molecular Weight | 230.26 | ||||
| Storage Details | Ambient | ||||
| Harmonised Tariff Code | 2918999090 |
Produktspezifikation
| Melting Point | 154 - 158 Deg C | ||||
| Specific rotation | +83 to +89.5 | ||||
| Heavy metals | <0.002% | ||||
| Loss on Drying | <0.5% | ||||
| Assay | 98.5 - 101.5% | ||||
| Appearance | White crystalline powder |
Sicherheitsinformation
| Pictograms |
|
||||
| Signal word | danger | ||||
| Hazard statements |
|
||||
| Precautionary statements |
|